Nuclear respiratory factor-1 (NRF1) induction as a powerful strategy to deter mitochondrial dysfunction and

Hyunho Lee1, Matteo Massaro1, Nourhan Abdelfattah2

  • 1Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas, USA.

Aging Cell
|December 25, 2024
PubMed

Insights

Nuclear respiratory factor-1 (NRF1) overexpression boosts mitochondrial function, preventing senescence in mesenchymal stem cells (MSCs). This enhances MSC potential for regenerative therapies and combats aging tissue dysfunction.

Area of Science:

  • Cellular senescence
  • Mitochondrial biology
  • Regenerative medicine

Background:

  • Mesenchymal stem cells (MSCs) are vital for regenerative therapies but susceptible to senescence.
  • Oxidative stress and mitochondrial dysfunction drive MSC senescence, impairing their therapeutic function.
  • Senescence is linked to aging tissues and elevated reactive oxygen species (ROS).

Purpose of the Study:

  • To investigate if nuclear respiratory factor-1 (NRF1) overexpression can prevent mesenchymal stem cell (MSC) senescence.
  • To determine if NRF1 enhances MSC metabolic function and mitigates oxidative stress-induced senescence.

Main Methods:

  • Mesenchymal stem cells (MSCs) were transfected with nuclear respiratory factor-1 (NRF1) messenger RNA (mRNA).
  • Single-cell RNA sequencing (scRNA-Seq) analyzed gene expression changes.
  • MSCs were exposed to hydrogen peroxide (H2O2) and replicative senescence models to assess NRF1's protective effects.

Main Results:

  • NRF1 mRNA transfection upregulated oxidative phosphorylation (OXPHOS) genes and suppressed senescence pathways.
  • NRF1 increased mitochondrial mass, reduced ROS production, and restored mitochondrial function and ATP production.
  • NRF1 overexpression decreased senescence markers (SA-β-gal, p53, p21, p16) and preserved mitochondrial health.

Conclusions:

  • Nuclear respiratory factor-1 (NRF1) induction effectively attenuates mesenchymal stem cell (MSC) senescence.
  • Enhancing mitochondrial function via NRF1 is a viable strategy to improve MSCs for regenerative medicine.
  • NRF1-mediated mitochondrial potentiation offers a potential therapeutic avenue for senescence-related disorders.